Literature DB >> 26093005

Relationship between quadriceps strength and patellofemoral joint chondral lesions after anterior cruciate ligament reconstruction.

Hai-Jun Wang1, Ying-Fang Ao1, Dong Jiang1, Xi Gong1, Yong-Jian Wang1, Jian Wang1, Jia-Kuo Yu2.   

Abstract

BACKGROUND: The incidence of the patellofemoral joint chondral lesions after anterior cruciate ligament reconstruction (ACLR) is disturbingly high. Few studies have assessed the factors affecting patellofemoral joint chondral lesions postoperatively. HYPOTHESIS: The recovery of quadriceps strength after ACLR could be associated with patellofemoral joint cartilage damage. STUDY
DESIGN: Cohort study; Level of evidence, 3.
METHODS: A total of 88 patients who underwent arthroscopic anatomic double-bundle ACLR with hamstring autografts received second-look arthroscopy at the time of metal staple removal at an average of 24.1 months (range, 12-51 months) postoperatively. All patients underwent standardized isokinetic strength testing for bilateral quadriceps and hamstrings 1 to 2 days before second-look arthroscopy. The patients were divided into 2 groups: Patients in group 1 had a ≥20% deficit on the peak torque measures for quadriceps compared with that of the contralateral knee, whereas those in group 2 had a <20% deficit on peak torque. Cartilage status at the patellofemoral joint and tibiofemoral joint were evaluated by second-look arthroscopy and the Outerbridge classification. Other assessments included the International Knee Documentation Committee (IKDC) score, Tegner and Lysholm scores, side-to-side difference on KT-2000 arthrometer, and range of motion.
RESULTS: There were 42 patients included in group 1 and 46 patients in group 2. The mean postoperative quadriceps peak torque of the involved knee compared with the contralateral knee was 70% (range, 57%-80%) in group 1 and 95% (range, 81%-116%) in group 2. For all patients, a significant worsening was seen in the patellar and trochlear cartilage (P = .030 and <.001, respectively) but not at the medial or lateral tibiofemoral joint after ACLR. A significant worsening in the status of both patellar and trochlear cartilage was seen after ACLR in group 1 (P = .013 and =.011, respectively) and of trochlear cartilage in group 2 (P = .006). Significantly fewer severe chondral lesions of the patella were found in group 2 than in group 1 (proportion of patients whose cartilage grade worsened: 26% vs 48%, P < .05; difference in cartilage grade: 0.09 vs 0.62, P < .05). There was no significant difference for trochlear chondral worsening between the 2 groups. No significant differences were detected between the 2 groups in terms of hamstring strength; Lysholm, Tegner, and IKDC scores; KT-2000 arthrometer anterior laxity; or range of motion.
CONCLUSION: Greater than 80% recovery of quadriceps strength after ACLR is associated with less severe patellar cartilage damage at short-term follow-up.
© 2015 The Author(s).

Entities:  

Keywords:  anterior cruciate ligament reconstruction; cartilage; patellofemoral joint; quadriceps strength; second-look arthroscopy

Mesh:

Year:  2015        PMID: 26093005     DOI: 10.1177/0363546515588316

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  9 in total

1.  Does patellar alignment or trochlear morphology predict worsening of patellofemoral disease within the first 5 years after anterior cruciate ligament reconstruction?

Authors:  Erin M Macri; Brooke E Patterson; Kay M Crossley; Josh J Stefanik; Ali Guermazi; Evelina Blomqwist; Karim M Khan; Tim S Whitehead; Hayden G Morris; Adam G Culvenor
Journal:  Eur J Radiol       Date:  2019-01-31       Impact factor: 3.528

2.  Patellofemoral MRI Alterations Following Single Bundle ACL Reconstruction with Hamstring Autografts Are Associated with Quadriceps Femoris Atrophy.

Authors:  Wei-Song Cai; Hao-Huan Li; Shin-Ichi Konno; Hironori Numazaki; Si-Qi Zhou; Yu-Biao Zhang; Guang-Tao Han
Journal:  Curr Med Sci       Date:  2019-12-16

3.  The Dynamic Effect of Anterior Cruciate Ligament Deficiency on Patellar Height.

Authors:  Francesco Luceri; Mattia Basilico; Cécile Batailler; Pietro Simone Randelli; Sébastien Lustig; Elvire Servien
Journal:  Indian J Orthop       Date:  2022-06-20       Impact factor: 1.033

4.  Factors Influencing the Progression of Patellofemoral Articular Cartilage Damage After Anterior Cruciate Ligament Reconstruction.

Authors:  Hui Huang; Zhengzhao Li; Shishi Luo; Jiaxuan Zheng; Gang Zhou; Guangji Wang
Journal:  Orthop J Sports Med       Date:  2022-07-14

5.  Return-to-sport quadriceps strength symmetry impacts 5-year cartilage integrity after anterior cruciate ligament reconstruction: A preliminary analysis.

Authors:  Caroline Brunst; Matthew P Ithurburn; Andrew M Zbojniewicz; Mark V Paterno; Laura C Schmitt
Journal:  J Orthop Res       Date:  2021-04-08       Impact factor: 3.494

6.  Comparison of hamstring and quadriceps strength after anatomical versus non-anatomical anterior cruciate ligament reconstruction: a retrospective cohort study.

Authors:  Hai Jiang; Lei Zhang; Rui-Ying Zhang; Qiu-Jian Zheng; Meng-Yuan Li
Journal:  BMC Musculoskelet Disord       Date:  2021-05-18       Impact factor: 2.362

7.  Quantitative analysis of T2 relaxation times of the patellofemoral joint cartilage 3 years after anterior cruciate ligament reconstruction.

Authors:  Chang-Wan Kim; Ali Hosseini; Lin Lin; Yang Wang; Martin Torriani; Thomas Gill; Alan J Grodzinsky; Guoan Li
Journal:  J Orthop Translat       Date:  2017-07-02       Impact factor: 5.191

8.  Prevalence and Predictors of Patellofemoral Osteoarthritis after Anterior Cruciate Ligament Reconstruction with Hamstring Tendon Autograft.

Authors:  Dhong Won Lee; Cheol Hynn Yeom; Du Han Kim; Tae Min Kim; Jin Goo Kim
Journal:  Clin Orthop Surg       Date:  2018-05-18

Review 9.  Risk factors of cartilage lesion after anterior cruciate ligament reconstruction.

Authors:  Zirong Huang; Jiaming Cui; Mingjin Zhong; Zhenhan Deng; Kang Chen; Weimin Zhu
Journal:  Front Cell Dev Biol       Date:  2022-09-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.